Abiomed at CRT 2023: Benefits of Impella-Supported High Risk PCI and Impella Innovation
Featured presentation on the time to clinical benefit of sotagliflozin in people with worsening heart failure
United States Johnson Medtech William Oneill Navin Kapur Arsalan Abu Cardiovascular Research Technologies
Source: dicardiology.com